Cancer patients test shorter antibiotic treatment for blood infections
NCT ID NCT07372131
Summary
This study is testing whether a personalized, shorter course of antibiotics works as well as the standard 10-day treatment for serious blood infections in cancer patients with very low white blood cell counts. Researchers want to see if stopping antibiotics sooner when a patient is stable is safe and helps prevent antibiotic resistance. They will compare two groups: one that stops antibiotics after 72 hours of stability and another that follows the standard longer treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAM NEGATIVE INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Microbiology and Virology - IRCCS Humanitas Research Hospital
RECRUITINGRozzano, Milan, 20089, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.